Sort
261,768 grants matching “gene therapy”
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
$1,286,326Christine M Albert · Brigham And Women'S Hospital · R01 · FY2014 · HL
Preclinical Studies of Living and Deceased Donor Liver Allograft Tolerance
$1,286,273Megan Sykes · Columbia University Health Sciences · R01 · FY2025 · AI
Assessment, Therapy and Prevention Of Autoimmune Disease
$1,286,209Lisa Rider · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Cincinnati Center of Neurofibromatosis Research
$1,286,182Nancy Ratner · Cincinnati Childrens Hosp Med Ctr · P50 · FY2009 · NS
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$1,286,039Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,286,039Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
WU-MDACC Inter-Institutional Molecular Imaging Center
$1,286,033Samuel Achilefu · Washington University · P50 · FY2016 · CA
SIMIAN VACCINE EVALUATION UNITS: Conduct Study P190
$1,286,013Vicki Traina-Dorge · Tulane University Of Louisiana · N01 · FY2015 · AI
Developmental Mechanisms of Human Idiopathic Scoliosis
$1,285,873Carol A Wise · Ut Southwestern Medical Center · P01 · FY2025 · HD
SIRT1, Epigenetics, and Metabolism in Skeletal Muscle Development, Regeneration, and Atrophy
$1,285,822Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Intellectual and Developmental Disabilities Research Center
$1,285,724M J Guralnick · University Of Washington · P50 · FY2020 · HD
SCOR IN PATHOBIOLOGY OF LUNG DEVELOPMENT
$1,285,707Children'S Hospital Boston · P50 · FY2000 · HL
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors
$1,285,694Nathanael Schiander Gray · Stanford University · OT2 · FY2025 · CA
Gene Therapy for SCID-X1 with Low Dose Busulfan and a SIN-lentiviral Vector
$1,285,631David A Williams · Boston Children'S Hospital · U01 · FY2023 · AI
Identification of immune evasion mechanisms in the osteosarcoma microenvironment
$1,285,628Troy McEachron · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,285,599Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Biomarkers for Huntington's Disease: Accelerating the Development of Therapies
$1,285,251Steven M Hersch · Massachusetts General Hospital · P01 · FY2011 · NS
Molecular and Cellular Therapies for Muscular Dystrophy
$1,285,240Stanley C Froehner · University Of Washington · P01 · FY2007 · NS
Biomarkers for Huntington's Disease: Accelerating the Development of Therapies
$1,285,098Steven M Hersch · Massachusetts General Hospital · P01 · FY2012 · NS
A comprehensive quality control testing strategy for engineered cells
$1,284,984Christopher John Tompkins · Kromatid, Inc. · R44 · FY2021 · TR
Genomic Diversity of Prostate Cancer Across the African Diaspora
$1,284,929Timothy R Rebbeck · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Engineered HSV for Treatment of Malignant Gliomas
$1,284,905Richard J. Whitley · University Of Alabama At Birmingham · P01 · FY2007 · CA
Immunobiology and Immunotherapy of Pediatric Tumors
$1,284,838Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Dystonia Coalition
$1,284,426Hyder A Jinnah · Emory University · U54 · FY2012 · NS
Rational Approaches to Melanoma Therapy
$1,284,372Jessie Villanueva · Wistar Institute · U54 · FY2025 · CA